From Molecular Classification to Targeted Therapeutics: The Changing Face of Systemic Therapy in Metastatic Gastroesophageal Cancer
Histological classification of adenocarcinoma or squamous cell carcinoma for esophageal cancer or using the Lauren classification for intestinal and diffuse type gastric cancer has limited clinical utility in the management of advanced disease. Germline mutations in E-cadherin (CDH1) or mismatch rep...
Main Authors: | Adrian Murphy, Ronan J. Kelly |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/896560 |
Similar Items
-
An Unusual Course of Metastatic Gastroesophageal Cancer
by: William H. Smith, et al.
Published: (2015-01-01) -
Molecular targeted therapies in metastatic melanoma
by: Chakraborty R, et al.
Published: (2013-06-01) -
Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach
by: Jin-On Jung, et al.
Published: (2020-01-01) -
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
by: Maryam Nakhjavani, et al.
Published: (2019-01-01) -
Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer
by: Brenen P. Swofford, et al.
Published: (2017-12-01)